Navigation Links
La Jolla Institute continues longtime collaboration with Kyowa Hakko Kirin California
Date:7/30/2013

, thanks to the partnership. Several of these potential therapies, including a drug that eases immune rejection problems in patients following organ transplantation, are in phase II clinical human studies, with others at various stages of development.

Dr. Kronenberg notes that academic-industry relationships are critical to advance the true mission of nonprofit academic research institutes. "Our ultimate goal is to see our findings put into direct use for improving human health," he notes. "It's the reason we exist." However, most research institutes aren't equipped for clinical trials and other aspects of drug development, which underscores the need for relationships between research nonprofits and pharmaceutical companies.

"KHK has the kind of long-term commitment that is necessary to take discoveries from the bench, into human clinical studies, and, if successful, into approved drugs," he says. "It's a complementary process without which many important breakthroughs might never get beyond the laboratory stage."

While research agreements between academic institutions and pharmaceutical companies are commonplace today, the collaboration between KKC and La Jolla Institute dates back to the Institute's founding in 1988, at a time when such arrangements were quite rare. "Our institute was fortunate to have been founded by a group of individuals with incredible vision and foresight about the necessity for strong linkages between academia and the pharmaceutical industry," says Dr. Kronenberg. "Back then it was a very novel even controversial idea."

"Their wisdom has proven extremely accurate," he adds. "Today such arrangements are a pivotal piece of drug discovery efforts throughout this country."


'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
2. La Jolla Institute scientist discovers key step in immune system-fueled inflammation
3. La Jolla institute identifies critical cell in fighting E. coli infection
4. La Jolla Institute identifies molecular switch enabling immune cells to better fight disease
5. La Jolla Institute discovers new player critical to unleashing T cells against disease
6. Diabetes Research Institute develops oxygen-generating biomaterial
7. Space research institute honors Sen. Hutchison with Pioneer Award
8. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
9. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
10. Cary Institute Hydrofracking Forum
11. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2015)... -- SoundView Technology Group issues a new research update following ... smart wallet. SoundView was one of the selected user groups to ... Wocket in multiple scenarios and outlets. Soundview ... making both debit and credit card payments.  ... company meets their plans in 2015, it would push our ...
(Date:3/23/2015)... 23, 2015  In the 2014 fiscal year, irs.gov ... losses. This figure accounts for a fraction of the ... Nilson Report, exceeds $11 billion globally. The polygraph has ... crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test in ...
(Date:3/20/2015)... Mar. 20, 2015 Research and Markets ... of the "India Sensors Market Forecast and ... The sensor market is projected to grow ... Consumer electronics, automotive, industrial and healthcare sectors ... the country. In addition, adoption of MEMS technology ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... at x-rays of hands, searching out the telltale signs of ... arthritis. With these clinical features at his side, he turns ... genome – to figure out what makes these people susceptible ... finally closed the circle between key genes identified in his ...
... cancer cells can be switched on using drugs, report ... The finding could lead to a new class of ... cancer types. , Popular new drugs such as Herceptin ... mutations that express themselves in large amounts, causing cancer ...
... – in other words, absorbing the past discoveries ... Carolina at Charlotte senior biology major Andrew Pierce ... unknown. , Pierce’s discovery has to do with ... of the European honeybee – perhaps the most ...
Cached Biology News:Breakthrough developments in rheumatoid arthritis reported 2Breakthrough developments in rheumatoid arthritis reported 3Breakthrough developments in rheumatoid arthritis reported 4U-M researchers discover gene switched off in cancer can be turned on 2U-M researchers discover gene switched off in cancer can be turned on 3Undergraduate research shows leaderless honeybee organizing 2Undergraduate research shows leaderless honeybee organizing 3Undergraduate research shows leaderless honeybee organizing 4
(Date:4/30/2015)... , April 30, 2015 Oxford Finance ... debt to life sciences and healthcare services companies, today ... term loan agreement with Celula, Inc., a diagnostic testing ... diseases, enabling better patient care and improved outcomes.  Proceeds ... development and expand the commercialization of its products in ...
(Date:4/30/2015)... , April 30, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that it ... Thursday, May 7, 2015 after the close of the ... call and webcast on Thursday, May 7, 2015 at ... the results and recent corporate developments. For ...
(Date:4/30/2015)... SureClinical, a leader in cloud-based health ... joined SureClinical’s executive team as Chief Financial Officer. ... executive with over 25 years in leadership roles ranging ... Ms. Morris joins SureClinical from Marrone Bio Innovations (MBI), ... of MBI from its founding in 2006 until 2011, ...
(Date:4/29/2015)... GUELPH, ON , April 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... twelve-month periods ended December 31, 2014. Biorem,s complete fiscal 2014 year-end financial ... FINANCIAL HIGHLIGHTS: 2014 , 2013 , 2014 ... 10,683 , 19,596 Gross profit 1,326 , ... 1,191 , 1,493 , 3,377 , ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4
... Deployment of Pharsight,s Automated PK/PD Data Management and ... ... Feb. 26 Pharsight,Corporation (Nasdaq: PHST ), a leading ... today announced that a,top Japanese-based pharmaceutical company has purchased a ...
... - $30 M plus potential annual revenue to ProMetic derived from first ... hyperimmune product ... ProMetic,s prion reduction technology in Kedrion,s ... manufacturing process, MONTREAL, Feb. 26 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc.,("ProMetic") ...
... DUBLIN, Calif., Feb. 25 SuperGen Inc.,(Nasdaq: ... discovery, rapid,development and commercialization of therapies for solid ... release its 2007,fourth quarter and fiscal year-end financial ... provide details of the Company,s financial,results, and provide ...
Cached Biology Technology:Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer 2Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer 3Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer 4Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer 5ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products 2ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products 3ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products 4SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008 2